mhurhangee/ep-ind-claims huggingface dataset:
A method for making dried fabricated fish chunks comprising: creating a mixture of surimi and one or more functional proteins in amounts sufficient to produce fabricated fish chunks comprising from 75 to 95% by weight of the mixture of surimi and functional proteins, wherein the mixture of surimi and functional proteins comprises from 50 to 100% by weight surimi and from 0 to 50% by weight of one or more non-surimi functional proteins selected from egg white protein, milk protein concentrate, wheat gluten, soy isolate protein, non-surimi fish protein, other types of white or light colored meat protein, and combinations thereof; and other comestible ingredients in amounts sufficient to produce fabricated fish chunks comprising from 5 to 25% by weight other comestible ingredients; wherein the other comestible ingredients are fiber, fat, carbohydrate, meal, or combinations thereof; blending the mixture while increasing the temperature to from 135 to 170°C; and cooling the mixture to a temperature to from 60 to 95°C to produce the fabricated fish chunks; further comprising drying the fabricated fish chunks at a temperature from 90 to 275°C and for a time period from 10 to 50 minutes, preferably wherein the fabricated fish chunks are dried at a temperature from 150 to 235°C, more preferred wherein the fabricated fish chunks are dried at a temperature from 160 to 190°C; wherein the dried fabricated fish chunk is a dried fabricated fish piece having a moisture content from 1 to 10% by weight. creating a mixture of surimi and one or more functional proteins in amounts sufficient to produce fabricated fish chunks comprising from 75 to 95% by weight of the mixture of surimi and functional proteins, wherein the mixture of surimi and functional proteins comprises from 50 to 100% by weight surimi and from 0 to 50% by weight of one or more non-surimi functional proteins selected from egg white protein, milk protein concentrate, wheat gluten, soy isolate protein, non-surimi fish protein, other types of white or light colored meat protein, and combinations thereof; and other comestible ingredients in amounts sufficient to produce fabricated fish chunks comprising from 5 to 25% by weight other comestible ingredients; wherein the other comestible ingredients are fiber, fat, carbohydrate, meal, or combinations thereof; blending the mixture while increasing the temperature to from 135 to 170°C; and cooling the mixture to a temperature to from 60 to 95°C to produce the fabricated fish chunks; further comprising drying the fabricated fish chunks at a temperature from 90 to 275°C and for a time period from 10 to 50 minutes, preferably wherein the fabricated fish chunks are dried at a temperature from 150 to 235°C, more preferred wherein the fabricated fish chunks are dried at a temperature from 160 to 190°C; wherein the dried fabricated fish chunk is a dried fabricated fish piece having a moisture content from 1 to 10% by weight.
A method for harvesting and subsequent passaging of human pluripotent stem cells without scraping and without substantial loss of viability comprising: incubating said human pluripotent stem cells in a formulation, said formulation comprising: sodium citrate, and a salt, wherein the salt is selected from the group consisting of NaCl, KCl, Na 2 HPO 3, NAH 2 PO 3, K 2 HPO 3, KH 2 PO 3 and NaHCO 3, wherein said formulation has an osmolarity of 150 -1500 mOsmol/Liter.
A pharmaceutical formulation, characterized by comprising aripiprazole monohydrate, mixture of sodium starch glycolate as super disintegrant and starch as disintegrant in which the proportion of aripiprazole monohydrate to sodium starch glycolate and starch mixture is in a range of 0.1 to 2.0 wherein the pharmaceutical formulation is obtained by wet granulation process containing ethyl alcohol and water.
An acyl phosphine oxide initiator wherein the acyl group is selected from the group consisting of a benzoyl group substituted by an urea group or an oxalylamide group; a 2,6-dimethyl benzoyl group substituted in position 3 by an urea group or an oxalylamide group; a 2,6-dimethoxy benzoyl group substituted in position 3 by an urea group or an oxalylamide group; a 2,4,6-trimethyl benzoyl group substituted in position 3 by an urea group or an oxalylamide group; and a 2,4,6-trimethoxybenzoyl group substituted in position 3 by an urea group or an oxalylamide group, with the proviso that the acyl phosphine oxide initiator contains no thiol group if the acyl group includes an urea group.
A light-emitting element mounting substrate, comprising: an alumina sintered body containing alumina crystal, zirconia crystal, and grain boundary phase, an intensity ratio I t /I m between a peak intensity I t of tetragonal zirconia crystal at 2θ ranging from 30° to 30.5° and a peak intensity I m of monoclinic zirconia crystal at 2θ ranging from 28° to 28.5° measured by an X-ray diffractometer using Cu-Kα radiation, being less than or equal to 35 excluding 0, characterized in that at least part of the zirconia crystal is lamellar-structured zirconia crystal. an alumina sintered body containing alumina crystal, zirconia crystal, and grain boundary phase, an intensity ratio I t /I m between a peak intensity I t of tetragonal zirconia crystal at 2θ ranging from 30° to 30.5° and a peak intensity I m of monoclinic zirconia crystal at 2θ ranging from 28° to 28.5° measured by an X-ray diffractometer using Cu-Kα radiation, being less than or equal to 35 excluding 0, characterized in that at least part of the zirconia crystal is lamellar-structured zirconia crystal.
A seal comprising: a sealing ring constructed with a first portion folded over a second portion so as to define at least one inner annular space bounded by said first and second portions (16, 14); and at least one hollow portion, which is at least partially annular, formed in said sealing ring in at least one of said first portion and said second portion, wherein said at least one hollow portion comprises an at least partially annular rib, the seal being characterized in that said annular rib is cross-shaped. a sealing ring constructed with a first portion folded over a second portion so as to define at least one inner annular space bounded by said first and second portions (16, 14); and at least one hollow portion, which is at least partially annular, formed in said sealing ring in at least one of said first portion and said second portion, wherein said at least one hollow portion comprises an at least partially annular rib, the seal being characterized in that said annular rib is cross-shaped.
A method for determining a status of a rechargeable battery indicating performance of the rechargeable battery mounted within the electronic device, the method being performed in an electronic device and comprising the steps of: performing a measurement over the rechargeable battery resulting in a measured value, wherein the measurement is performed during running of at least one application, comparing the measured value with a predetermined value resulting in a difference value, wherein the predetermined value is a value of a measurement from running the at least one application when the rechargeable battery is new or just manufactured or just put into the terminal or determined from a nominal specification of a battery type corresponding to the battery type of the rechargeable battery of the electronic device, and wherein the at least one application is already included in the electronic device with a known current consumption, determining the status of the rechargeable battery by comparing the difference value with a preset threshold value, which status indicates whether the rechargeable battery need to be replaced or not; and displaying either, based on the determined status, that the rechargeable battery need to be replaced or that the rechargeable battery is fine in the electronic device. performing a measurement over the rechargeable battery resulting in a measured value, wherein the measurement is performed during running of at least one application, comparing the measured value with a predetermined value resulting in a difference value, wherein the predetermined value is a value of a measurement from running the at least one application when the rechargeable battery is new or just manufactured or just put into the terminal or determined from a nominal specification of a battery type corresponding to the battery type of the rechargeable battery of the electronic device, and wherein the at least one application is already included in the electronic device with a known current consumption, determining the status of the rechargeable battery by comparing the difference value with a preset threshold value, which status indicates whether the rechargeable battery need to be replaced or not; and displaying either, based on the determined status, that the rechargeable battery need to be replaced or that the rechargeable battery is fine in the electronic device.
A signal processing device (1, 31, 41, 51) comprising: a first medium; a second medium; a lipid interface (4, 33, 54) arranged between the first medium and the second medium, wherein the lipid interface (4, 33, 54) comprises a plurality of lipid molecules; an input transducer arranged to apply an input signal to the lipid interface (4, 33, 54), wherein the input signal is arranged to generate a mechanical pulse in the lipid interface (4, 33, 54); and an output transducer arranged to receive an output signal by detecting a mechanical response in the lipid interface (4, 33, 54) from the mechanical pulse generated in the lipid interface (4, 33, 54) by the input transducer; wherein the lipid interface (4, 33, 54) is arranged to propagate the mechanical pulse from the input transducer via the lipid interface (4, 33, 54) to the output transducer; and wherein the input transducer is arranged to induce a current flow through the lipid interface (4, 33, 54) to excite sound waves in the lipid interface (4, 33, 54). a first medium; a second medium; a lipid interface (4, 33, 54) arranged between the first medium and the second medium, wherein the lipid interface (4, 33, 54) comprises a plurality of lipid molecules; an input transducer arranged to apply an input signal to the lipid interface (4, 33, 54), wherein the input signal is arranged to generate a mechanical pulse in the lipid interface (4, 33, 54); and an output transducer arranged to receive an output signal by detecting a mechanical response in the lipid interface (4, 33, 54) from the mechanical pulse generated in the lipid interface (4, 33, 54) by the input transducer; wherein the lipid interface (4, 33, 54) is arranged to propagate the mechanical pulse from the input transducer via the lipid interface (4, 33, 54) to the output transducer; and wherein the input transducer is arranged to induce a current flow through the lipid interface (4, 33, 54) to excite sound waves in the lipid interface (4, 33, 54).
Method for manufacturing a fiber-reinforced concrete column used in the construction industry, in which method one or more pipes, such as a steel pipe, is brought to a base, and fixed to the aforementioned base, after which the pipe is filled with fiber-reinforced concrete simultaneously with vibrating the the pipe, and preferably also the concrete, wherein the pipe is filled with fiber-reinforced concrete via a lead-in in the bottom part of the pipe, which lead-in is on the side of the pipe, and in that vibration of the pipe is performed from the top of the pipe.
Electrical machine, in particular generator for supplying the vehicle electrical system of a motor vehicle, having a laminated stator with a multi-phase stator winding and having a laminated rotor with an excitation winding which is disposed in grooves and which preferably supplies the excitation of the machine together with permanent magnets (24,25) disposed on the rotor circumference, characterized in that the rotor laminated package is subdivided in the axial direction into at least two partial packages (21a, b) with mutually aligned grooves and poles offset with respect to one another, wherein the electrically excited poles (35, 36; 37, 38) adjacent to a groove opening each have different pole pitches (τ1, τ2).
A semiconductor apparatus, comprising: a driver circuit wafer including a plurality of driver circuits arranged in an array; a bonding metal layer formed over the driver circuit wafer; a horizontally continuous functional device epi-structure layer formed over the bonding metal layer and covering the driver circuits, wherein the bonding metal layer includes a plurality of bonding metal pads arranged in an array and isolated from each other, each of the driver circuits corresponding to one of the bonding metal pads; and a dielectric isolation layer arranged between the driver circuit wafer and the functional device epi-structure layer, characterised in that the dielectric isolation layer includes first protrusion structures and second protrusion structures surrounding each of the first protrusion structures, wherein each first protrusion structure is formed between one of the bonding metal pads and one of the driver circuits, and has a through hole formed from an upper surface of the first protrusion structure to a lower surface of the first protrusion structure, at least a portion of the bonding metal pad being arranged in the through hole, and each of the first protrusion structures and the second protrusion structures surrounding the first protrusion structure define a recess surrounding the first protrusion structure. a driver circuit wafer including a plurality of driver circuits arranged in an array; a bonding metal layer formed over the driver circuit wafer; a horizontally continuous functional device epi-structure layer formed over the bonding metal layer and covering the driver circuits, wherein the bonding metal layer includes a plurality of bonding metal pads arranged in an array and isolated from each other, each of the driver circuits corresponding to one of the bonding metal pads; and a dielectric isolation layer arranged between the driver circuit wafer and the functional device epi-structure layer, characterised in that the dielectric isolation layer includes first protrusion structures and second protrusion structures surrounding each of the first protrusion structures, wherein each first protrusion structure is formed between one of the bonding metal pads and one of the driver circuits, and has a through hole formed from an upper surface of the first protrusion structure to a lower surface of the first protrusion structure, at least a portion of the bonding metal pad being arranged in the through hole, and each of the first protrusion structures and the second protrusion structures surrounding the first protrusion structure define a recess surrounding the first protrusion structure.
A pharmaceutical composition comprising: (a) the 2-((1-benzyl-3-indazolyl)methoxy)-2-methylpropionic acid having the following structural formula: (b) at least one of (i) a pressure lowering agent selected from ACE-inhibitors, ARBs and CCBs, and/or (ii) a cholesterol lowering agent selected from statin derivatives, or any pharmaceutically acceptable salt and ester thereof, and (c) at least one pharmaceutically acceptable vehicle, wherein said ACE-inhibitor is selected from the group consisting of alacepril, altiopril calcium, benzoylcaptopril, captopril, captopril-cysteine, captopril-glutathione, ceronapril, converstatin, enalapril, enalaprilat, epicaptopril, fosinopril, fosinopril sodium, fosinoprilat, hemorphin-4, indolapril, indolaprilat, lisinopril, moveltipril, pentopril, perindopril, perindoprilat, quinapril, quinapril hydrochloride, quinaprilat, ramipril, ramiprilat, spirapril, spirapril hydrochloride, spiraprilat, trandolapril, trandolaprilat, zabicipril, zabiciprilat, zofenopril, zofenoprilat, said ARB is selected from the group consisting of candesartan, cilexetil, irbesartan, losartan, olmesartan, telmisartan, valsartan, and pratosartan, said CCBs is selected from the group consisting of amlodipine, aranidipine, barnidipine, benidipine, cilnidipine, efonidipine, elgodipine, felodipine, isradipine, lacidipine, lercanidipine, manidipine, nicardipine, nifedipine, nilvadipine, nimodipine, nisoldipine, nitrendipine, diltiazem, clentiazem, bepridil, bencyclane, etafenone, flunarizine, lidoflazine, lomerizine, mibefradil, phendilin, prenylamine, semotiadil, terodiline, gallopamil, and verapamil, said statin derivative is selected from the group consisting of lovastatin, mevastatin, pravastatin and simvastatin. (a) the 2-((1-benzyl-3-indazolyl)methoxy)-2-methylpropionic acid having the following structural formula: (b) at least one of (i) a pressure lowering agent selected from ACE-inhibitors, ARBs and CCBs, and/or (ii) a cholesterol lowering agent selected from statin derivatives, or any pharmaceutically acceptable salt and ester thereof, and (c) at least one pharmaceutically acceptable vehicle,
A method implemented by a client device, the method comprising: sending a heartbeat request to a server device in a lease period, and receiving a heartbeat request response from the server device; and determining, by the client device, a retry sending adaptive interval in response to the heartbeat request response being abnormal, wherein determining the retry sending interval comprises determining the retry sending interval based at least in part on an anomaly determining time point of the heartbeat request response and a lease expiration time point using a reverse exponential backoffalgorithm, and sending a retry heartbeat request to the server device again after the retry sending interval is past, until the lease period expires or a corresponding heartbeat request response is normal. sending a heartbeat request to a server device in a lease period, and receiving a heartbeat request response from the server device; and determining, by the client device, a retry sending adaptive interval in response to the heartbeat request response being abnormal, wherein determining the retry sending interval comprises determining the retry sending interval based at least in part on an anomaly determining time point of the heartbeat request response and a lease expiration time point using a reverse exponential backoffalgorithm, and sending a retry heartbeat request to the server device again after the retry sending interval is past, until the lease period expires or a corresponding heartbeat request response is normal.
A solenoid comprising: a movable shaft linearly movable in an axial direction; a movable coil unit (130, 140, 145) coupled to the movable shaft, the movable coil unit comprising a coil, a winding member allowing the coil to be wound there around, and a movable support fixedly coupling the winding member to the movable shaft; and a magnetic field forming unit (150, 160, 170) forming a magnetic field in a direction perpendicular with respect to that of a current flowing in the movable coil unit, wherein when a current is applied to the movable coil unit, the movable coil unit is moved by a magnetic field formed by the magnetic field forming unit to move the movable shaft, characterized in that the winding member is formed by a plurality of laminated main prepregs, the plurality of main prepregs of the winding member being spaced apart from one another, and the coil being wound in a space between the plurality of main prepregs, and the winding member further comprises a plurality of auxiliary prepregs laminated between the main prepregs, wherein the auxiliary prepegs have a length shorter than that of the main prepegs forming the space corresponding to a thickness of the coil between the main prepegs, and wherein the coil is wound in the space. a movable shaft linearly movable in an axial direction; a movable coil unit (130, 140, 145) coupled to the movable shaft, the movable coil unit comprising a coil, a winding member allowing the coil to be wound there around, and a movable support fixedly coupling the winding member to the movable shaft; and a magnetic field forming unit (150, 160, 170) forming a magnetic field in a direction perpendicular with respect to that of a current flowing in the movable coil unit, wherein when a current is applied to the movable coil unit, the movable coil unit is moved by a magnetic field formed by the magnetic field forming unit to move the movable shaft, characterized in that the winding member is formed by a plurality of laminated main prepregs, the plurality of main prepregs of the winding member being spaced apart from one another, and the coil being wound in a space between the plurality of main prepregs, and the winding member further comprises a plurality of auxiliary prepregs laminated between the main prepregs, wherein the auxiliary prepegs have a length shorter than that of the main prepegs forming the space corresponding to a thickness of the coil between the main prepegs, and wherein the coil is wound in the space.
A mass of metal fibers, wherein the metal fibers of the mass of metal fibers - have a discrete length; - have a cross section, wherein the cross section has two neighbouring straight lined sides with an included angle of less than 90° and one or more irregularly shaped curved sides, - have an average equivalent diameter of less than 100 μm; and - have a standard deviation between fibers of the equivalent fiber diameter of less than 25% of the equivalent fiber diameter. - have a discrete length; - have a cross section, wherein the cross section has two neighbouring straight lined sides with an included angle of less than 90° and one or more irregularly shaped curved sides, - have an average equivalent diameter of less than 100 μm; and - have a standard deviation between fibers of the equivalent fiber diameter of less than 25% of the equivalent fiber diameter.
Method for forming one or more three-dimensional objects for an optoelectronic lighting device comprising a carrier with an optoelectronic semiconductor component, comprising the following steps: - providing a carrier of an optoelectronic lighting device, wherein an optoelectronic semiconductor component is arranged on the carrier, wherein a construction region that is partly delimited by the carrier is defined, the optoelectronic semiconductor component facing said construction region, - introducing a polymerizable liquid into the construction region, - exposing the construction region in order to form one or more solid polymers from the polymerizable liquid in a curing zone comprised by the construction region, in order to form one or more three-dimensional objects from said one or more solid polymers in the curing zone, - wherein an ineffective region is formed during the process of exposing the construction region, polymerization being inhibited in said ineffective region, wherein the curing zone is arranged between the carrier and the ineffective region. - providing a carrier of an optoelectronic lighting device, wherein an optoelectronic semiconductor component is arranged on the carrier, wherein a construction region that is partly delimited by the carrier is defined, the optoelectronic semiconductor component facing said construction region, - introducing a polymerizable liquid into the construction region, - exposing the construction region in order to form one or more solid polymers from the polymerizable liquid in a curing zone comprised by the construction region, in order to form one or more three-dimensional objects from said one or more solid polymers in the curing zone, - wherein an ineffective region is formed during the process of exposing the construction region, polymerization being inhibited in said ineffective region, wherein the curing zone is arranged between the carrier and the ineffective region.